C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/38 (2006.01) A61K 35/14 (2006.01) A61K 38/08 (2006.01) A61K 39/00 (2006.01) A61K 39/245 (2006.01) A61K 39/395 (2006.01) A61K 39/42 (2006.01) A61P 31/20 (2006.01) C07K 7/06 (2006.01) C07K 14/045 (2006.01) C07K 16/08 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2403681
The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.
L'invention concerne des composés synthétiques, des anticorps qui reconnaissent ces composés et se fixent à eux, des polynucléotides codant pour ces composés, et des cellules effectrices immunes mobilisés en réponse à la présence de ces épitopes. L'invention concerne également des procédés permettant, d'une part, d'activer une réaction immunitaire et, d'autre part, de traiter un sujet par immunothérapie par administration des compositions décrites dans cette invention.
Borden Ladner Gervais Llp
Genzyme Corporation
LandOfFree
Therapeutic anti-cytomegalovirus compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic anti-cytomegalovirus compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic anti-cytomegalovirus compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1663306